参考文献/References:
[1] 王雯雯,赵恒立.基于“阳化气,阴成形”理论治疗痛风性关节炎研究进展[J].陕西中医,2022,43(9):1319-1321.
[2] 中华医学会风湿病学分会.原发性痛风诊断和治疗指南[J].中华风湿病学杂志,2011,15(6):410-413.
[3] Khanna D,Khanna PP,Fitzgerald JD,et al.2012 American college of rheumatology guidelines for management of gout.Part 2:Therapy and antiinflammatory prophylaxis of acute gouty arthritis[J].Arthritis Care Research,2012,64(10):1447-1461.
[4] 蒋彦章.秋水仙碱:药物过致量严重毒性及死亡的风险[J].药物流行病学杂志,2011,20(2):102-105.
[5] 杨 梅,李琳荣,王雪梅,等.痛风的临床文献研究[J].山西中医学院学报,2007,8(6):1-3.
[6] 童晓岚,兰济乐,张 芯,等.基于数据挖掘中药治疗痛风配方规律研究[J].陕西中医,2021,42(11):1619-1624.
[7] 韩利文,陈善军,董 榕,等.网络药理学在中药复杂作用模式研究中的应用进展[J].山东科学,2021,34(6):22-31.
[8] Stelzer G,Rosen N,Plaschkes I,et al.The GeneCards suite:From gene data mining to disease genome sequence analyses[J].Current Protocols in Bioinformatics,2016,54(1):30-33.
[9] Davis AP,Grondin CJ,Johnson RJ,et al.The comparative toxicogenomics database:Update 2019[J].Nucleic Acids Research,2019,47(1):948-954.
[10] Szklarczyk D,Gable AL,Lyon D,et al.String v11:Protein-protein association networks with increased coverage,supporting functional discovery in genome-wide experimental datasets[J].Nucleic Acids Research,2019,47(1):607-613.
[11] Bader GD,Hogue CW.An automated method for finding molecular complexes in large protein interaction networks[J].BMC Bioinformatics,2003,4(1):1-27.
[12] Huang DW,Sherman BT,Lempicki RA.Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J].Nature Protocols,2009,22(8):44-57.
[13] Nutmakul T.A review on benefits of quercetin in hyperuricemia and gouty arthritis[J].Saudi Pharmaceutical Journal,2022,6(5):50-61.
[14] Pan D,Li N,Liu Y,et al.Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway[J].International Immunopharmacology,2018,55:174-182.
[15] Souza MR,Paula CA,Resende MP,et al.Pharmacological basis for use of lychnophora trichocarpha in gouty arthritis:Anti-hyperuricemic and anti-inflammatory effects of its extract,fraction and constituents[J].Journal of Ethnopharmacology,2012,142(3):845-850.
[16] Chen WP,Yu C,Hu PF,et al.Stigmasterol blocks cartilage degradation in rabbit model of osteoarthritis[J].Acta Biochimica Polonica,2012,59(4):20-23.
[17] Vasanthi P,Nalini G,Rajasekhar G.Role of tumor necrosis factor-alpha in rheumatoid arthritis:A review[J].APLAR Journal of Rheumatology,2007,62(4):270-274.
[18] Rock KL,Kataoka H,Lai JJ.Uric acid as a danger signal in gout and its comorbidities[J].Nature Reviews Rheumatology,2013,49(6):13-23.
[19] Yu S,Hong Q,Wang Y,et al.High concentrations of uric acid inhibit angiogenesis via regulation of the Kruppel-like factor 2-vascular endothelial growth factor-a axis by miR-92a[J].Circulation Journal,2015,6(4):286-289.
[20] 张静雯,汪 宁,邱红霞,等.非布司他治疗早期糖尿病肾病合并高尿酸血症疗效及对患者肾功能影响研究[J].陕西医学杂志,2020,49(2):209-211.
[21] Liu Y,Zhao Q,Yin Y,et al.Serum levels of IL-17 are elevated in patients with acute gouty arthritis[J].Biochemical and Biophysical Research Communications,2018,497(3):897-902.
[22] Conforti AC,Spreafico R,Qian HL,et al.Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18[J].The Journal of Immunology,2011,187(11):5842-5850.
[23] Kim EK,Choi EJ.Compromised MAPK signaling in human diseases:An update[J].Archives of Toxicology,2015,89(6):867-882.
[24] Bondeson J,Blom AB,Wainwright S,et al.The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis[J].Arthritis Rheumatism,2010,62(3):647-657.
[25] Lawrence T,Natoli G.Transcriptional regulation of macrophage polarization:Enabling diversity with identity[J].Nature Reviews Immunology,2011,11(11):750-761.
[26] Ghosh S,Karin M.Missing pieces in the NF-κB puzzle[J].Cell,2002,109(2):81-96.
[27] Yamamoto M,Yaginuma K,Tsutsui H,et al.ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules[J].Genes to Cells,2004,9(11):1055-1067.
[28] 郭晓波,杨 乐,蔺 京,等.骨髓增殖性肿瘤患者发生血栓事件的危险因素[J].陕西医学杂志,2019,48(3):307-310.
[29] Drutskaya MS,Efimov GA,Kruglov AA,et al.Can we design a better anti-cytokine therapy?[J].Journal of Leukocyte Biology,2017,102(3):783-790.
[30] Shen HH,Yang YX,Meng X,et al.NLRP3:A promising therapeutic target for autoimmune diseases[J].Autoimmunity Reviews,2018,17(7):694-702.